Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Tissue
Reexamination Certificate
2011-08-09
2011-08-09
Snow, Bruce E (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Tissue
Reexamination Certificate
active
07993412
ABSTRACT:
Nanomaterials for neural and orthopedic prostheses are disclosed. Composite carbon nanofibers enhance neuronal growth and minimize glial scar tissue formation. Methods and compositions to promote neuronal growth and minimize scar tissue formation during prolonged monitoring and treatment of neural tissue are disclosed. Composite polyurethane carbon nanofiber is a suitable material for neural implant. Composite carbon nanomaterials decrease adhesion of astrocytes and fibroblasts.
REFERENCES:
patent: 4776853 (1988-10-01), Klement et al.
patent: 4795436 (1989-01-01), Robinson
patent: 4902508 (1990-02-01), Badylak et al.
patent: 4998239 (1991-03-01), Strandjord et al.
patent: 5281422 (1994-01-01), Badylak et al.
patent: 5292328 (1994-03-01), Hain et al.
patent: 5306311 (1994-04-01), Stone et al.
patent: 5372821 (1994-12-01), Badylak et al.
patent: 5415704 (1995-05-01), Davidson
patent: 5573784 (1996-11-01), Badylak et al.
patent: 5733337 (1998-03-01), Carr, Jr. et al.
patent: 5744515 (1998-04-01), Clapper
patent: 6106913 (2000-08-01), Scardino et al.
patent: 6183255 (2001-02-01), Oshida
patent: 6262017 (2001-07-01), Dee et al.
patent: 6270347 (2001-08-01), Webster et al.
patent: 6291070 (2001-09-01), Arpac et al.
patent: 6319264 (2001-11-01), Tormala et al.
patent: 6344367 (2002-02-01), Naya et al.
patent: 6355198 (2002-03-01), Kim et al.
patent: 6368859 (2002-04-01), Atala
patent: 6396208 (2002-05-01), Oda et al.
patent: 6572672 (2003-06-01), Yadav et al.
patent: 6669706 (2003-12-01), Schmitt et al.
patent: 6670179 (2003-12-01), Mattson et al.
patent: 6689374 (2004-02-01), Chu et al.
patent: 6756286 (2004-06-01), Moriceau et al.
patent: 6790455 (2004-09-01), Chu et al.
patent: 6797514 (2004-09-01), Berenson et al.
patent: 6805898 (2004-10-01), Wu et al.
patent: 6881249 (2005-04-01), Anderson et al.
patent: 6929539 (2005-08-01), Schutz et al.
patent: 2002/0167118 (2002-11-01), Billiet et al.
patent: 2002/0173033 (2002-11-01), Hammerick et al.
patent: 2002/0173213 (2002-11-01), Chu et al.
patent: 2003/0040809 (2003-02-01), Goldmann et al.
patent: 2003/0050711 (2003-03-01), Laurencin et al.
patent: 2004/0028875 (2004-02-01), Van Rijn et al.
patent: 2004/0104672 (2004-06-01), Shiang et al.
patent: 2004/0131753 (2004-07-01), Smith et al.
patent: 2004/0171323 (2004-09-01), Shalaby
patent: 2004/0241211 (2004-12-01), Fischell et al.
patent: 2006/0173471 (2006-08-01), Carr, Jr. et al.
Dee et al., “Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials,”J. Biomed. Mater. Res., 40:371-77 (1998).
Webster et al., “Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics,”J. Biomed. Mater. Res., 51:475-83 (2000).
Webster et al., “Enhanced functions of osteoblasts on nanophase ceramics,”Biomaterials, 21:1803-10 (2000).
Curtis & Wilkinson, “Review. Topographical control of cells,”Biomaterials, 18(24):1573-83 (1997).
Puleo & Bizios, “RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion,”Bone, 12:271-76 (1991).
Siegel, “Creating nanophase materials,”Scientific American, 275(6):74 (1996).
Webster et al., “Design and evaluation of nanophase alumina for orthopaedic/dental applications,”Nanostructured Materials, 12:983-86 (1999).
Webster et al., “Enhanced surface and mechanical properties of nanophase ceramics to achieve orthopaedic/dental implant efficacy,”Key Engineering Materials, vols. 192-195, pp. 321-24 (Proceedings of the 13th international symposium on ceramics in medicine, Bologna, Italy, 2000 (Trans Tech Publications, 2001).
Webster et al., “Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin,”Tissue Engineering, 7(3):291-301 (2001).
Webster et al., “Nanoceramic surface roughness enhances osteoblast and osteoclast functions for improved orthopaedic/dental implant efficacy,”Scripta Mater., 44:1639-42 (2001).
Jean-Louis Pariente et al., “In vitro biocompatibility assessment of naturally derive and synthetic biomaterials using normal human urothelial cells,”J. Biomed. Mater. Res., 55(1), (2001), pp. 33-39.
Malachy J. Gleeson et al., “The use of alloplastic biomaterials in bladder substitution,”J. Urol., 148, (1992), pp. 1377-1382.
Janeta Nikolovski et al., Smooth muscle cell adhesion to tissue engineering scaffolds,Biomat., 21, (2000), pp. 2025-2032.
Anthony Atala et al., “Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle,”J. Urol., 150, (1993), pp. 608-612.
M. J. Lyndon et al., “Cellular interactions with synthetic polymer surfaces in culture,”Biomat. 6, (1985), pp. 396-402.
A. S. G. Curtis et al., “Adhesion of cells to polystyrene surfaces,”J. Cell Biol., 97, (1983), pp. 1500-1506.
Joseph A. Chinn et al., “Enhancement of serum fibronectin adsorption and the clonal plating efficiencies of Swiss mouse 3T3 fibroblast and MM14 mouse myoblast cells on polymer substrates modified by radiofrequency plasma deposition,”J. Colloid Interface Sci., 127, (1989), pp. 67-87.
Paul Goldhaber, “The influence of pore size on carcinogenicity of subcutaneously implanted Millipore filters,”Proc. Am. Assoc. Cancer Res., 3 (1961), p. 28.
J. Brauker et al., “Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue,”Transplant Proc., 24, (1992); p. 2924.
Paul Weiss, “In vitro experiments on the factors determining the course of the outgoing nerve fiber,”J. Exp. Zool., 68, (1945), pp. 393-448.
G. A. Dunn et al., “Alignment of fibroblasts on grooved surfaces described by a simple geometric transformation,”J. Cell Sci., 83, (1986), pp. 313-340.
J. Meyle et al., “Variation in contact guidance by human cells on a microstructured surface,”J. Biomed. Mater. Res., 29, (1995), pp. 81-88.
John A. Schmidt et al., “Macrophage response to microtextured silicone,”Biomat., 12, (1992), pp. 385-389.
Karen M. Haberstroh et al., “The effects of sustained hydrostatic pressure on select bladder smooth muscle cell functions,”J. Urol., 162, (1999), pp. 2114-2118.
Jinming Gao et al., “Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells,”J. Biomed. Mat. Res., 42, (1998), pp. 417-424.
Mark A. Schubert et al., “Role of oxygen in biodegradation of poly(etherurethane urea) elastomers,”J. Biomed. Mat. Res., 34, (1997), pp. 519-530.
Thomas J. Webster et al., “Osteoblast adhesion on nanophase ceramics,”Biomaterials, 20, (1999), pp. 1221-1227.
M. Conley et al., “Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro,”Biomaterials, 19, (1998), pp. 1255-1268.
Susan L. Ishaug-Riley et al., “Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers,”Biomaterials19, (1998), pp. 1405-1412.
Susan L. Ishaug-Riley et al., “Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films,”Biomaterials, 20, (1999), pp. 2245-2256.
Laurence S. Baskin et al., “Cellular Signaling in the Bladder,” www.bioscience.org.,Frontiers in Bioscience, 2, d592-595, (1997), 8 pgs.
Gunilla Dahlfors et al., “Vascular Endothelial Growth Factor and Transforming Growth Factor-β1 Regulate the Expression of Insulin-Like Growth Factor-Binding Protein-3, -4, and -5 in Large Vessel Endothelial Cells,”The Endocrinology Society, vol. 141, No. 6, (2000), pp. 2062-2067.
Antonios G. Mikos et al., “Preparation and Characterization of poly(L-lactic acid) foams,”Polymer, vol. 35, No. 5, (1994), pp. 1068-1077.
Kenjiro Yamakawa et al., “Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Gr
McKenzie Janice L.
Webster Thomas J.
Barnes & Thornburg LLP
Purdue Research Foundation
Snow Bruce E
LandOfFree
Nanofibers as a neural biomaterial does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanofibers as a neural biomaterial, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanofibers as a neural biomaterial will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2713002